Arbutus Biopharma Corpora... (ABUS)
NASDAQ: ABUS
· Real-Time Price · USD
4.62
0.29 (6.70%)
At close: Sep 10, 2025, 1:59 PM
License Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 9.6M | 8.8M | +1100.00% |
| Mar 31, 2025 | 800K | -423K | -34.59% |
| Dec 31, 2024 | 1.22M | 579K | +89.91% |
| Sep 30, 2024 | 644K | 2K | +0.31% |
| Jun 30, 2024 | 642K | -53K | -7.63% |
| Mar 31, 2024 | 695K | 295K | +73.75% |
| Dec 31, 2023 | 400K | -2.8M | -87.50% |
| Sep 30, 2023 | 3.2M | 200K | +6.67% |
| Jun 30, 2023 | 3M | -1.1M | -26.83% |
| Mar 31, 2023 | 4.1M | 1.84M | +81.42% |
| Dec 31, 2022 | 2.26M | -140K | -5.83% |
| Sep 30, 2022 | 2.4M | -8.62M | -78.23% |
| Jun 30, 2022 | 11.02M | 1.39M | +14.45% |
| Mar 31, 2022 | 9.63M | 8.64M | +870.97% |
| Dec 31, 2021 | 992K | -868K | -46.67% |
| Sep 30, 2021 | 1.86M | 1.84M | +8354.55% |
| Jun 30, 2021 | 22K | -37K | -62.71% |
| Mar 31, 2021 | 59K | -912K | -93.92% |
| Dec 31, 2020 | 971K | 927K | +2106.82% |
| Jun 30, 2018 | 44K | n/a | n/a |